Custom peptides & antibodies
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
175
NCT03729271
Hydrogen Breath Test an Instrument to Predict Rifaximin-Response in Irritable Bowel Syndrome Predominant Diarrhea
Phase: Phase 4
Role: Collaborator
Start: Jan 9, 2020
Completion: Jan 1, 2026
Loading map...